|
|
|
|
|
Prognostic value of changes in serum uric acid and erythrocyte distribution width in patients with AECOPD |
Wei hong, Zhang hong, Weng Yun-long, Huang xin |
Department of Emergency Center, First Affiliated Hospital of Anhui Medical University, Hefei 230001, China |
|
|
Abstract Objective To explore the relationship between the levels of serum uric acid (SUA) and red cell distribution width (RDW) and in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods The patients with AECOPD who were admitted to Lui′an Hospital of Anhui Medical Unversity from January 2016 to February 2018 were selected from the department of emergency medicine, respiratory medicine and critical medicine. Patients with AECOPD were divided into surviving discharged group (n=64) and in-hospital death group (n=41). The laboratory indicators of RDW (%) and SUA (μmoL/L) were collected on the first, the third, the fifth and the seventh day of admission. The best truncation values of RDW and SUA were obtained by ROC curve analysis. Multivariate Logistic regression was used to determine the independent risk factors for in-hospital mortality in AECOPD patients. Results〓 The age and Hb level of the death group were higher than those of the survival and discharge group, and the difference was statistically significant (P<0.05). RDW levels on the third day of admission (AUC 0.784, 95%CI0.694-0.859, the best cut-off value:>13.8), the fifth day (AUC 0.938, 95%CI0.874-0.976, the best cut-off value:>13.6), the seventh day (AUC 0.990, 95%CI0.946-1.000, the best cut-off value: >13.5) all had good predictions of in-hospital mortality in AECOPD patients. SUA levels on the 3rd day of admission (AUC 0.661, 95%CI0.562-0.751, the best cut-off value: >328.7), the 5th day (AUC 0.790, 95%CI 0.700-0.864, the best cut-off value: >323.7), the 7th day (AUC 0.860,95%CI0.777-0.921, the best cut-off value: >327.0) all had good predictions of in-hospital mortality of AECOPD patients. With the extension of admission time, the AUC value increased RDW 0.501<0.784<0.938<0.990, SUA 0.580<0.661<0.790<0.860). Age (HR1.068, 95%CI1.017-1.123), the 7th day of admission RDW (HR10.698, 95%CI2.873-39.813), and the 7th day of admission SUA (HR1.016, 95%CI1.006-1.027) were all independent risk factors for in-hospital mortality in AECOPD patients. Conclusion Increased levels of RDW and SUA are independent risk factors for in-hospital mortality in patients with AECOPD. Continuous detection of SUA and RDW during treatment has important clinical value in judging prognosis, especially on the seventh day after admission, elevated levels of SUA and RDW may predict poor prognosis in patients with AECOPD.
|
|
Corresponding Authors:
Zhang Hong, E-mail: zhanghong20070703@163.com
|
|
|
|
[1]Vestbo J, Hurd SS, Agustí AG,et al.Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. Am J Respir Crit Care Med, 2013, 187(4): 347-365.
[2]Chalder MJ, Wright CL, Morton KJ, et al. Study protocol for an evaluation of the effectiveness of ‘care bundles’ as a means of improving hospital care and reducing hospital readmission for patients with chronic obstructive pulmonary disease(COPD)[J]. BMC Pulm Med, 2016, 16:35.
[3]Yin P, Lv H, Li Y,et al.Hip fracture patients who experience a greater fluctuation in RDW during hospital course are at heightened risk for all-cause mortality: a prospective study with 2-year follow-up[J]. Osteoporos Int, 2018, 29(7):1559-1567.
[4]Uemura Y, Shibata R, Takemoto K, et al. Elevation of red blood cell distribution width during hospitalization predicts mortality in patients with acute decompensated heart failure[J]. J Cardiol, 2016, 67(3):268-273.
[5]Li Y, Zhao Y, Feng L, et al. Comparison of the prognostic values of inflammation markers in patients with acute pancreatitis: a retrospective cohort study[J]. BMJ Open, 2017, 7(3):e013 206.
[6]Emiroglu N, Cengiz FP,Bahal AG, et al. Red blood cell distribution width and neutrophil-to-lymphocyte ratio in patients with cutaneous vasculitis[J]. Ann Clin Lab Sci, 2017, 47(2):162-165.
[7]慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2014年修订版)[J]. 国际呼吸杂志, 2014, 34(1):1041-1057.
[8]Ycas JW, Horrow JC, Horne BD. Persistent increase in red cell sizedistribution width after acute diseases: A biomarker of hypoxemia[J]. Clin Chim Acta, 2015, 448:107-117.
[9]Ozgul G, Seyhan EC, zgül MA,et al.Red Blood Cell Distribution Width in Patients With Chronic Obstructive Pulmonary Disease and Healthy Subjects[J]. Arch Bronconeumol, 2017, 53(3):107-113.
[10]Seyhan EC, zgül MA, Tutar N, et al. Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease[J]. COPD:, 2013, 10(4):416-424.
[11]Salvagno GL, Sanchis-Gomar F, Picanza A, et al. Red blood cell distribution width: A simple parameter with multiple clinical applications[J]. Crit Rev Clin Lab Sci, 2015, 52(2):86-105.
[12]Braun E, Domany E, Kenig Y, et al. Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia[J]. Crit Care, 15(4):R194.
[13]Gorelik O, Izhakian S, Barchel D, et al. Changes in red cell distribution width during hospitalization for community-acquired pneumonia: clinical characteristics and prognostic significance[J]. Lung, 2016, 194(6):985-995.
[14]冯博琳,李建强,郭瑞萍,等.慢性阻塞性肺疾病急性发作期患者血清尿酸与肺功能血气分析的相关性研究[J].中国药物与临床, 2015, 15(6):849-851.
[15]Wan YF, Zheng YL, Du YP, et al. Utility of uric acid as a risk marker of extubation success in chronic obstructive pulmonary disease[J]. Clin Lab, 2015, 61(3-4):337-344.
[16]Pascual-Figal DA, Hurtado-Martínez JA, Redondo B, et al. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients[J]. Eur J Heart Fail, 2007, 9(5):518-524.
[17]Hunninghake DB. Cardiovascular disease in chronic obstructive pulmonary disease[J]. Proc Am Thorac Soc, 2005, 2(1):44-49.
[18]Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2012, 185(10):1065-1072. |
|
|
|